{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:20:57Z","timestamp":1761675657448},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/grf.0b013e31818092df","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T20:00:11Z","timestamp":1236283211000},"page":"527-532","source":"Crossref","is-referenced-by-count":7,"title":["Human Papillomavirus Vaccines: An Update for Gynecologists"],"prefix":"10.1097","volume":"51","author":[{"given":"KEVIN A.","family":"AULT","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210126","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/524875","article-title":"Risk of female human papillomavirus acquisition associated with first male sex partner","volume":"197","author":"Winer","year":"2008","journal-title":"J Infect Dis"},{"key":"R2-7-20210126","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"key":"R3-7-20210126","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/cncr.10927","article-title":"Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women","volume":"95","author":"Castle","year":"2002","journal-title":"Cancer"},{"key":"R4-7-20210126","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R5-7-20210126","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1067\/mob.2003.164","article-title":"Clinical findings among young women with genital human papillomavirus infection","volume":"188","author":"Mao","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R6-7-20210126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1179\/095741903235001876","article-title":"Virus-like particles as a potential vaccine for human papillomavirus","volume":"14","author":"Ault","year":"2003","journal-title":"Papillomavirus Rep"},{"key":"R7-7-20210126","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N Engl J Med"},{"key":"R8-7-20210126","first-page":"1915","article-title":"Efficacy and safety of a prophylactic quadrivalent human papillomavirus (types 6\/11\/16\/18) L1 virus-like-particle vaccine in the prevention of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a randomized controlled trial","volume":"356","author":"Koutsky","year":"2007","journal-title":"N Engl J Med"},{"key":"R9-7-20210126","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"A quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Suzanne","year":"2007","journal-title":"NEJM"},{"key":"R10-7-20210126","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1503\/cmaj.070948","article-title":"Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials","volume":"177","author":"Rambout","year":"2007","journal-title":"CMAJ"},{"key":"R11-7-20210126","first-page":"1","article-title":"quadrivalent human papillomavirus vaccine","volume":"56","year":"2007","journal-title":"MMWR"},{"key":"R13-7-20210126","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvant bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"}],"container-title":["Clinical Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003081-200809000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T01:52:58Z","timestamp":1618365178000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-200809000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0b013e31818092df","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}